首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
【24h】

Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.

机译:糖尿病肾病患者发展中的危险因素及糖尿病兄弟姐妹的治疗模式。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Diabetic siblings of patients with treated kidney failure from diabetic kidney disease are at a 5-fold increased risk of future kidney failure. The objective of this study is to define risk factors for kidney disease, clinical features, and treatment patterns in diabetic siblings of patients with diabetes with diabetic kidney disease. STUDY DESIGN: Cross-sectional analysis using data collected from diabetic siblings of patients with diabetic kidney disease. SETTING & PARTICIPANTS: 295 diabetic siblings with mean diabetes duration of 15 years from within a 400-mile radius of Cleveland, OH, or Winston-Salem, NC. PREDICTORS: Demographic data, diabetes duration, blood pressure (BP), access to health care, and diabetes control. OUTCOMES: Albuminuria (defined as urinary albumin-creatinine ratio >or= 30 mg/g, with microalbuminuria with albumin of 30 to 300 mg/g and macroalbuminuria with albumin > 300 mg/g), renal function. MEASUREMENTS: BP, urinary albumin-creatinine ratio, serum creatinine, glycosylated hemoglobin (HbA(1c)), estimated glomerular filtration rate. RESULTS: Mean diabetes duration was 14.6 +/- 10.6 years. Albuminuria was present in 46% of participants. In individuals with diabetes duration of 11 to 15 years, 25% had microalbuminuria and 18.2% had macroalbuminuria. Despite a positive family history and a high prevalence of albuminuria, only 35.3% of participants had a target systolic BP less than 130 mm Hg. HbA(1c) levels were 7% or greater in 57.4% of patients, and 26.4% of participants were smokers. Only 58% of patients received angiotensin-converting enzyme inhibitors or receptor blockers. In microalbuminuric participants, HbA(1c) level was greater than 10% in 28.6% versus 13.3% in those without albuminuria (P = 0.02). LIMITATIONS: A control group of diabetic siblings without a family history of diabetic kidney disease was not obtained. CONCLUSIONS: Diabetic siblings of patients with diabetic kidney disease have a high prevalence of albuminuria and poor glycemic and BP control. Targeting these high-risk individuals for interventions to improve their BP and blood glucose control might prevent or slow the progression of diabetic kidney disease.
机译:背景:患有糖尿病性肾病的患有肾衰竭的患者的兄弟姐妹患上未来肾衰竭的风险增加了5倍。这项研究的目的是确定患有糖尿病肾病的糖尿病患者的糖尿病兄弟姐妹的肾脏疾病,临床特征和治疗方式的危险因素。研究设计:横断面分析使用从糖尿病肾病患者的糖尿病兄弟姐妹收集的数据。地点和参与者:295名糖尿病兄弟姐妹,平均糖尿病病程为15年,来自俄亥俄州克利夫兰或北卡罗来纳州温斯顿塞勒姆的400英里范围内。预测者:人口统计数据,糖尿病持续时间,血压(BP),获得医疗保健和糖尿病控制的机会。结果:白蛋白尿(定义为尿白蛋白-肌酐比>或= 30 mg / g,微量白蛋白尿的白蛋白为30-300 mg / g,巨蛋白尿的白蛋白> 300 mg / g),肾功能。测量:血压,尿白蛋白-肌酐比率,血清肌酐,糖基化血红蛋白(HbA(1c)),估计的肾小球滤过率。结果:平均糖尿病病程为14.6 +/- 10.6年。 46%的参与者中存在蛋白尿。在糖尿病持续时间为11至15岁的个体中,有25%的人患有微量白蛋白尿,有18.2%的人患有大量白蛋白尿。尽管有积极的家族史和高蛋白尿症患病率,但只有35.3%的参与者的收缩压目标血压低于130毫米汞柱。 HbA(1c)水平在57.4%的患者中为7%或更高,并且26.4%的参与者为吸烟者。只有58%的患者接受了血管紧张素转换酶抑制剂或受体阻滞剂。在微量白蛋白尿患者中,HbA(1c)水平在28.6%中大于10%,而在没有蛋白尿的患者中为13.3%(P = 0.02)。局限性:未获得没有糖尿病肾病家族史的糖尿病兄弟姐妹对照组。结论:糖尿病肾病患者的糖尿病兄弟姐妹的白蛋白尿患病率较高,血糖和血压控制较差。针对这些高危人群进行干预以改善其血压和血糖控制可能会预防或减慢糖尿病肾病的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号